Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Breast biopsy & localization · Michigan | Breast biopsy & localization · Illinois | |
|---|---|---|
| Surgeons, 2024 | 102 | 165 |
| Medicare fee-for-service cases | 5,736 | 9,253 |
| Growth since 2019 (Medicare FFS) | −6.4%/yr | −2.3%/yr |
| Forecast cases (Medicare FFS) | 5,320 in 2030 | 9,520 in 2030 |
| Forecast growth | −1.2%/yr to 2030 | +0.5%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 7.3 | 7.1 |
| Medicare Advantage share | 66% | 47% |
| Out of hospital | 5% (−1 pts since 2019) | 8% (+2 pts since 2019) |
| Cases per surgeon | 56 | 56 |
| Top 10 surgeons' share | 22% | 17% |
| Surgeons growing | 16 | 19 |
| New since the base year | 15 | 31 |
| Likely to stop billing it | 13 by 2026 | 26 by 2026 |
| Forecast miss, 1 year (procedure) | 3% | 3% |
| Company payments per surgeon | $1,786 | $5,568 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.